Recombinant glycoprotein gB2/gD2 vaccine data

CHIR reported that its HSV-2 vaccine in its MF59 adjuvant is safe and effective in producing neutralizing antibodies. Results of a Phase I/II trial showed production of neutralizing antibodies in the...